LAVITRANO, MARIALUISA
LAVITRANO, MARIALUISA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
2024 Ilari, A; Cogliati, V; Sherif, N; Grassilli, E; Ramazzotti, D; Cordani, N; Cazzaniga, G; Di Bella, C; Lavitrano, M; Cazzaniga, M; Cerrito, M
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
2024 Ronchini, C; Caprioli, C; Tunzi, G; D'Amico, F; Colombo, E; Giani, M; Foti, G; Conconi, D; Lavitrano, M; Passerini, R; Pase, L; Capizzi, S; Mastrilli, F; Alcalay, M; Orecchia, R; Natoli, G; Pelicci, P
Olfactory receptor genes and chromosome 11 structural aberrations: Players or spectators?
2024 Redaelli, S; Grati, F; Tritto, V; Giannuzzi, G; Recalcati, M; Sala, E; Villa, N; Crosti, F; Roversi, G; Malvestiti, F; Zanatta, V; Repetti, E; Rodeschini, O; Valtorta, C; Catusi, I; Romitti, L; Martinoli, E; Conconi, D; Dalprà, L; Lavitrano, M; Riva, P; Bentivegna, A
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells
2024 Giambra, M; Di Cristofori, A; Raimondo, F; Rigolio, R; Conconi, D; Chiarello, G; Tabano, S; Antolini, L; Nicolini, G; Bua, M; Ferlito, D; Carrabba, G; Giussani, C; Lavitrano, M; Bentivegna, A
AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
2023 Ardizzoia, A; Jemma, A; Redaelli, S; Silva, M; Bentivegna, A; Lavitrano, M; Conconi, D
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
2023 Betzler, A; Strobel, H; Abou Kors, T; Ezić, J; Lesakova, K; Pscheid, R; Azoitei, N; Sporleder, J; Staufenberg, A; Drees, R; Weissinger, S; Greve, J; Doescher, J; Theodoraki, M; Schuler, P; Laban, S; Kibe, T; Kishida, M; Kishida, S; Idel, C; Hoffmann, T; Lavitrano, M; Grassilli, E; Brunner, C
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
2023 Rainone, P; Valtorta, S; Villa, C; Todde, S; Cadamuro, M; Bertoli, G; Conconi, D; Lavitrano, M; Moresco, R
Genomic Complexity and Complex Chromosomal Rearrangements in Genetic Diagnosis: Two Illustrative Cases on Chromosome 7
2023 Villa, N; Redaelli, S; Farina, S; Conconi, D; Sala, E; Crosti, F; Mariani, S; Colombo, C; Dalprà, L; Lavitrano, M; Bentivegna, A; Roversi, G
Insights into the Peritumoural Brain Zone of Glioblastoma: CDK4 and EXT2 May Be Potential Drivers of Malignancy
2023 Giambra, M; Di Cristofori, A; Conconi, D; Marzorati, M; Redaelli, S; Zambuto, M; Rocca, A; Roumy, L; Carrabba, G; Lavitrano, M; Roversi, G; Giussani, C; Bentivegna, A
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells
2023 Cordani, N; Mologni, L; Piazza, R; Cogliati, V; Pepe, F; Capici, S; DI BELLA, C; Jaconi, M; Cerrito, M; Villa, M; Tettamanti, P; Cavaletti, G; Lavitrano, M; Cazzaniga, M
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification
2023 L'Imperio, V; Wulczyn, E; Plass, M; Müller, H; Tamini, N; Gianotti, L; Zucchini, N; Reihs, R; Corrado, G; Webster, D; Peng, L; Chen, P; Lavitrano, M; Liu, Y; Steiner, D; Zatloukal, K; Pagni, F
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
2023 Cordani, N; Mologni, L; Piazza, R; Tettamanti, P; Cogliati, V; Mauri, M; Villa, M; Malighetti, F; DI BELLA, C; Jaconi, M; Cerrito, M; Cavaletti, G; Lavitrano, M; Cazzaniga, M
A Systematic Review of the Current Status and Quality of Radiomics for Glioma Differential Diagnosis
2022 Brancato, V; Cerrone, M; Lavitrano, M; Salvatore, M; Cavaliere, C
Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B
2022 Conconi, D; Jemma, A; Giambra, M; Redaelli, S; Croci, G; Dalprà, L; Lavitrano, M; Bentivegna, A
BTK, the new kid on the (oncology) block?
2022 Grassilli, E; Cerrito, M; Lavitrano, M
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms
2022 Villa, C; Rivellini, E; Lavitrano, M; Combi, R
Characterization of Chromosomal Breakpoints in 12 Cases with 8p Rearrangements Defines a Continuum of Fragility of the Region
2022 Redaelli, S; Conconi, D; Sala, E; Villa, N; Crosti, F; Roversi, G; Catusi, I; Valtorta, C; Recalcati, M; Dalpra, L; Lavitrano, M; Bentivegna, A
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022 Scagliotti, A; Capizzi, L; Cazzaniga, M; Ilari, A; De Giorgi, M; Cordani, N; Gallazzi, M; Bruno, A; Pelosi, G; Albini, A; Lavitrano, M; Grassilli, E; Cerrito, M
Exome Sequencing in an ADSHE Family: VUS Identification and Limits
2022 Villa, C; Arrigoni, F; Rivellini, E; Lavitrano, M; De Gioia, L; Ferini-Strambi, L; Combi, R
Matrix metalloproteinases, purinergic signaling, and epigenetics: hubs in the spinal neuroglial network following peripheral nerve injury
2022 De Luca, C; Virtuoso, A; Cerasuolo, M; Gargano, F; Colangelo, A; Lavitrano, M; Cirillo, G; Papa, M